Therapeutic Efficacy Of Ipilimumab, An Anti-CTLA-4 Monoclonal Antibody, In Patients With Metastatic Melanoma Unresponsive To Prior Systemic Treatments: Clinical And Immunological Evidence From Three Patient Cases
Anna Maria Di Giacomo, Riccardo Danielli, Massimo Guidoboni, Luana Calabrò, Dora Carlucci, Clelia Miracco, Luca Volterrani, Maria Antonietta Mazzei, Maurizio Biagioli, Maresa Altomonte, Michele Maio
Twitter
Facebook
LinkedIn
Email